Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trialSamuel M. Brown, Sonal Pannu, Cameron Hypes et al.|The Lancet Respiratory Medicine|2023Cited by 19